Compare Novavax Inc (NVAX) vs BlackRock TCP Capital Corp (TCPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs BlackRock TCP Capital Corp — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while BlackRock TCP Capital Corp trades at $3.24 (market cap $270.17M). The key difference: Novavax Inc is far larger — about 4.8× BlackRock TCP Capital Corp's market cap, and BlackRock TCP Capital Corp pays a 26.09% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | TCPC | |
|---|---|---|
Market Cap | $1.30B | $270.17M |
Sector | Health | Financials |
52-Week High | $11.19 | $7.64 |
52-Week Low | $6.22 | $3.14 |
Enterprise Value | $800.50M | — |
Dividend Yield | — | 26.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About BlackRock TCP Capital Corp
BlackRock TCP Capital Corp is a finance company specializing in middle-market lending. It aims for high returns through income and capital appreciation while prioritizing principal protection. The company invests in debt securities and earns revenue from interest payments, fees, and some equity appreciation.
Read more on TCPC →
